APA (7th ed.) Citation

Giesel, F., P, F., T, K., L, S., S, W., C, Z., . . . C, K. (2013). Contrast-enhanced ultrasound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial ¹⁷⁷Lu/⁹⁰Y-DOTATOC and ²¹³Bi-DOTATOC radiopeptide therapy. Experimental Oncology.

Chicago Style (17th ed.) Citation

Giesel, F.L, Flechsig P, Kuder T, Schwartz L, Wulfert S, Zechmann C, Bruchertseifer F, Haberkorn U, and Kratochwil C. "Contrast-enhanced Ultrasound Monitoring of Perfusion Changes in Hepatic Neuroendocrine Metastases After Systemic Versus Selective Arterial ¹⁷⁷Lu/⁹⁰Y-DOTATOC and ²¹³Bi-DOTATOC Radiopeptide Therapy." Experimental Oncology 2013.

MLA (8th ed.) Citation

Giesel, F.L, et al. "Contrast-enhanced Ultrasound Monitoring of Perfusion Changes in Hepatic Neuroendocrine Metastases After Systemic Versus Selective Arterial ¹⁷⁷Lu/⁹⁰Y-DOTATOC and ²¹³Bi-DOTATOC Radiopeptide Therapy." Experimental Oncology, 2013.

Warning: These citations may not always be 100% accurate.